Rentokil Initial plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc, a foreign private issuer, covers the month of September 2022. The report specifically discloses transactions by persons discharging managerial responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation. The filing date is September 14, 2022.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the company. It focuses exclusively on a specific executive share transaction.
- Transaction Type: Exercise of Performance Share Plan (PSP) awards and subsequent sale of shares.
- Shares Involved: 18,957 ordinary shares.
- Transaction Price: £5.60 per share.
- Total Proceeds: £106,159.20.
- Consideration for Exercise: Nil.
Material Changes
The filing does not report material changes to the company's financial position or operations. It reports a change in the shareholding of Gary Booker, Chief Marketing, Innovation and Strategy Officer, resulting from the exercise of awards granted in March 2018.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is a regulatory notification of a completed transaction.
Key Facts for Investor Verification
- Executive Action: Gary Booker exercised PSP awards and sold 18,957 shares on September 14, 2022.
- Valuation: The sale price was £5.60 per share, totaling approximately £106,159.
- Regulatory Compliance: The transaction was reported under UK Market Abuse Regulation requirements.
- Scope Limitation: This document does not provide financial performance data for Rentokil Initial plc; investors should refer to Form 20-F or interim reports for financial metrics.